University Hospital Galway

At University Hospital Galway, oncology research focuses on melanoma, breast cancer, and chronic lymphocytic leukemia, with studies also addressing ER+/HER2- early breast cancer. These trials are designed to compare new treatment approaches with current standards and to help reduce the risk of cancer recurrence or disease progression.

• Testing new immunotherapy combinations for melanoma after surgery
• Evaluating endocrine-based options to prevent breast cancer recurrence
• Comparing treatment strategies for previously untreated chronic lymphocytic leukemia

Overall, this area of research aims to improve long-term outcomes by identifying more effective and better-targeted cancer treatments.

Clinical trials in immune-related and dermatology conditions at this site include atopic dermatitis, hidradenitis suppurativa, and other inflammatory skin disorders. The research is centered on finding therapies that can better control symptoms and help patients who have not responded well to existing treatments.

• Assessing new treatment options for moderate to severe atopic dermatitis
• Studying therapies for hidradenitis suppurativa in adolescents and adults
• Exploring improved control of chronic inflammatory skin disease

These studies reflect a strong interest in advancing care for persistent immune-mediated and skin conditions.

Research in this area addresses COVID-19, severe community-acquired pneumonia, and mpox virus disease. The trials are focused on evaluating treatments for hospitalized patients, understanding clinical outcomes, and improving care during serious infectious illnesses.

• Testing therapies for hospitalized patients with moderate and severe COVID-19
• Evaluating treatment approaches for severe pneumonia
• Observing outcomes in patients with mpox virus disease

This infectious disease portfolio highlights efforts to improve recovery and survival in acute viral and respiratory illness.

Studies in digestive and metabolic medicine include ulcerative colitis, obesity, and classic congenital adrenal hyperplasia. The research is aimed at improving long-term disease control, reducing treatment burden, and identifying safer or more effective therapies.

• Assessing long-term treatment options for ulcerative colitis
• Investigating new approaches for obesity and related cardiometabolic risk
• Evaluating therapies that may reduce glucocorticoid use in congenital adrenal hyperplasia

These trials show a broad interest in chronic conditions that affect digestion, hormones, and metabolism.